Transglutaminase-2 Is Involved in All-Trans Retinoic Acid-Induced Invasion and Matrix Metalloproteinases Expression of SH-SY5Y Neuroblastoma Cells via NF-κB Pathway |
Lee, Hye-Ja
(College of Pharmacy, Dongguk University)
Park, Mi-Kyung (College of Pharmacy, Dongguk University) Bae, Hyun-Cheol (Division of Cancer Biology, Research Institute, National Cancer Center) Yoon, Hee-Jung (Division of Cancer Biology, Research Institute, National Cancer Center) Kim, Soo-Youl (Division of Cancer Biology, Research Institute, National Cancer Center) Lee, Chang-Hoon (College of Pharmacy, Dongguk University) |
1 | Kim, D. S., Park, S. S., Nam, B. H., Kim, I. H. and Kim, S. Y. (2006) Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation. Cancer Res. 66, 10936-10943. DOI ScienceOn |
2 | Brodeur, G. M. (2002). Signifi cance of intratumoral genetic heterogeneity in neuroblastomas. Med. Pediatr. Oncol. 38, 112-113. DOI |
3 | Cha, D. S., Shin, T. Y., Eun, J. S., Kim, D. K. and Jeon, H. (2011) Anti-metastatic properties of the leaves of Eriobotrya japonica. Arch. Pharm. Res. 34, 425-436. DOI |
4 | Cho, S. Y., Jeong, E. M., Lee, J. H., Kim, H. J., Lim, J., Kim, C. W., Shin, D. M., Jeon, J. H., Choi, K. and Kim, I. G. (2012) Doxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell death. Mol. Cells 33, 235-241. DOI |
5 | Cianfarani, S. and Rossi, P. (1997) Neuroblastoma and insulin-like growth factor system. New insights and clinical perspectives. Eur. J. Pediatr. 156, 256-261. DOI |
6 | Condello, S., Caccamo, D., Currò, M., Ferlazzo, N., Parisi, G. and Ientile, R. (2008) Transglutaminase 2 and NF-kappaB interplay during NGF-induced differentiation of neuroblastoma cells. Brain Res. 1207, 1-8. DOI |
7 | De Bosscher, K., Vanden Berghe, W. and Haegeman, G. (2006) Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 25, 6868-6886. DOI |
8 | DuBois, S. G., Kalika, Y., Lukens, J. N., Brodeur, G. M., Seeger, R. C., Atkinson, .J B., Haase, G. M., Black, C. T., Perez, C., Shimada, H., Gerbing, R., Stram, D. O. and Matthay, K. K. (1999) Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J. Pediatr. Hematol. Oncol. 21, 181-189. DOI |
9 | Farina, A. R., Masciulli, M. P., Tacconelli, A., Cappabianca, L., De Santis, G., Gulino, A. and Mackay, A. R. (2002) All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells. Cell Growth Differ. 13, 343-354. |
10 | Akimov, S. S., Krylov, D., Fleischman, L. F. and Belkin, A. M. (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J. Cell Biol. 148, 825-838. DOI ScienceOn |
11 | Ara, T. and DeClerck, Y. A. (2006) Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev. 25, 645-657. |
12 | Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M. S., Bachelerie, F., Thomas, D. and Hay, R. T. (1995) Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNAbinding and transcriptional activities of NF-kappa B. Mol. Cell Biol. 15, 2689-2696. |
13 | Sato, S., Seki, N., Hotta, Y. and Tabata, S. (1995) Expression profiles of a human gene identifi ed as a structural homologue of meiosisspecific recA-like genes. DNA Res. 2, 183-186. DOI |
14 | Beck, K. E., De Girolamo, L. A., Griffi n, M. and Billett, E. E. (2006) The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells. Neurosci. Lett. 405, 46-51. DOI |
15 | Boccaccio, C. and Comoglio, P. M. (2006) Invasive growth: a METdriven genetic programme for cancer and stem cells. Nat. Rev. Cancer 6, 637-645. DOI |
16 | Zemskov, E. A., Janiak, A., Hang, J., Waghray, A. and Belkin, A. M. (2006) The role of tissue transglutaminase in cell-matrix interactions. Front Biosci. 11, 1057-1076. DOI |
17 | Park, M. K., Lee, H. J., Shin, J., Noh, M., Kim, S. Y. and Lee, C. H. (2011) Novel participation of transglutaminase-2 through c-Jun Nterminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells. Biochim. Biophys. Acta 1811, 1021-1029. DOI |
18 | Priglinger, S. G., Alge, C. S., Neubauer, A. S., Kristin, N., Hirneiss, C., Eibl, K., Kampik, A. and Welge-Lussen, U. (2004) TGF-beta2-induced cell surface tissue transglutaminase increases adhesion and migration of RPE cells on fi bronectin through the gelatin-binding domain. Invest. Ophthalmol. Vis. Sci. 45, 955-963. DOI |
19 | Redfern, C. P., Lovat, P. E., Malcolm, A. J. and Pearson, A. D. (1995) Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid. Eur. J. Cancer 31A, 486-494. |
20 | Roy Choudhury, S., Karmakar, S., Banik, N. L. and Ray, S. K. (2012) Targeting angiogenesis for controlling neuroblastoma. J. Oncol. 2012, 782020. |
21 | Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E. and Birchmeier, C. (1995) Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373, 699-702. DOI |
22 | Sugiura, Y., Shimada, H., Seeger, R. C., Laug, W. E. and DeClerck, Y. A. (1998) Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res. 58, 2209-2216. |
23 | Woessner, J. F. Jr. (2002) MMPs and TIMPs--an historical perspective. Mol. Biotechnol. 22, 33-49. DOI |
24 | Natoli, G. and Chiocca, S. (2008) Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation. Sci. Signal. 1, pe1. DOI |
25 | Lee, J. S., Kim, I. H. and Kim, S. Y. (2006) Changes in gene expression with increased transglutaminase 2 in a SH-SY5Y cell line. Front Biosci. 11, 2774-2781. DOI |
26 | Kweon, S. M., Lee, Z. W., Yi, S. J., Kim, Y. M., Han, J. A., Paik, S. G. and Ha, S. S. (2004) Protective role of tissue transglutaminase in the cell death induced by TNF-alpha in SH-SY5Y neuroblastoma cells. J. Biochem. Mol. Biol. 37, 185-191. DOI |
27 | Lee, A. C. (2012) Neuroblastoma: the challenge remains. Singapore Med. J. 53, 1-2. |
28 | Lee, C. H. and Kim, S. Y. (2009) NF-kappaB and therapeutic approach. Biomol. Ther. 17, 219-240. DOI |
29 | Lee, J., Kim, Y. S., Choi, D. H., Bang, M. S., Han, T. R., Joh, T. H. and Kim, S. Y. (2004) Transglutaminase 2 induces nuclear factorkappaB activation via a novel pathway in BV-2 microglia. J. Biol. Chem. 279, 53725-53735. DOI |
30 | Mackay, A. R., Ballin, M., Pelina, M. D., Farina, A. R., Nason, A. M., Hartzler, J. L. and Thorgeirsson, U. P. (1992) Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 12, 168-184. |
31 | Mehta, K., Fok, J., Miller, F. R., Koul, D. and Sahin, A. A. (2004) Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin. Cancer Res. 10, 8068-8076. DOI |
32 | Modak, S. and Cheung, N. K. (2010) Neuroblastoma: Therapeutic strategies for a clinical enigma. Cancer Treat. Rev. 36, 307-317. DOI ScienceOn |
33 | Mueller, S. and Matthay, K. K. (2009) Neuroblastoma: biology and staging. Curr. Oncol. Rep. 11, 431-438. DOI |
34 | Garattini, E., Gianni, M. and Terao, M. (2007) Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations. Curr. Pharm. Des. 13, 1375-1400. DOI |
35 | Murtaugh, M. P., Dennison, O., Stein, J. P. and Davies, P. J. (1986) Retinoic acid-induced gene expression in normal and leukemic myeloid cells. J. Exp. Med. 163, 1325-1330. DOI |
36 | Festuccia, C., Bologna, M., Vicentini, C., Tacconelli, A., Miano, R., Violini, S. and Mackay, A. R. (1996) Increased matrix metalloproteinase- 9 secretion in short-term tissue cultures of prostatic tumor cells. Int. J. Cancer 69, 386-393. DOI |
37 | Freemantle, S. J., Spinella, M. J. and Dmitrovsky, E. (2003) Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22, 7305-7315. DOI ScienceOn |
38 | Guidez, F., Li, A. C., Horvai, A., Welch, J. S. and Glass, C. K. (1998) Differential utilization of Ras signaling pathways by macrophage colony-stimulating factor (CSF) and granulocyte-macrophage CSF receptors during macrophage differentiation. Mol. Cell Biol. 18, 3851-3861. |
39 | Gurney, J. G., Ross, J. A., Wall, D. A., Bleyer, W. A., Severson, R. K. and Robison, L. L. (1997) Infant cancer in the U.S.: histologyspecifi c incidence and trends, 1973 to 1992. J. Pediatr. Hematol. Oncol. 19, 428-432. DOI |
40 | Joshi, S., Guleria, R., Pan, J., DiPette, D. and Singh, U. S. (2006) Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells. Oncogene 25, 240-247. |
41 | Karin, M. and Ben-Neriah, Y. (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18, 621-663. DOI ScienceOn |